Also trades as: INDIAGLYCO.BO (BSE) · $vol 0M
INDIAGLYCO.NS NSE
India Glycols Limited
1W: -2.4%
1M: +30.1%
3M: -72.2%
YTD: -69.8%
1Y: -64.4%
3Y: -3.3%
5Y: -9.4%
₹302.75 ($3.14)
+3.95 (+1.32%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$65.2B
+5.6% ▲
5Y CAGR: +9.6%
Total Liabilities
$35.9B
-8.4% ▼
5Y CAGR: +4.0%
Shareholders Equity
$29.3B
+30.0% ▲
5Y CAGR: +20.2%
Cash & Investments
$889M
+62.6% ▲
5Y CAGR: +17.6%
Total Debt
$16.9B
-10.6% ▼
5Y CAGR: +8.3%
Net Debt
$16.6B
-8.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $70M | $20M | $270M | $68M | $319M |
| Short-Term Investments | $360M | $457M | $477M | $479M | $571M |
| Cash & ST Investments | $431M | $2.8B | $746M | $547M | $889M |
| Net Receivables | $6.4B | $6.1B | $5.0B | $3.6B | $3.5B |
| Inventory | $6.9B | $7.5B | $11.1B | $11.7B | $8.9B |
| Other Current Assets | $2.0B | -$273M | $2.4B | $2.3B | $1.7B |
| Total Current Assets | $16.1B | $16.5B | $19.4B | $18.2B | $15.0B |
| Property, Plant & Equip. | $25.5B | $28.3B | $32.8B | $39.2B | $45.9B |
| Goodwill & Intangibles | $17M | $19M | $16M | $14M | $15M |
| Long-Term Investments | $3.4B | $3.2B | $3.4B | $3.8B | $3.9B |
| Other Non-Current Assets | -$5K | $74M | $550M | $529M | $469M |
| Total Non-Current Assets | $30.2B | $32.1B | $36.7B | $43.6B | $50.3B |
| Total Assets | $46.3B | $48.6B | $56.2B | $61.8B | $65.2B |
| — Liabilities — | |||||
| Accounts Payable | $3.8B | $4.6B | $10.7B | $9.8B | $7.9B |
| Short-Term Debt | $5.0B | $5.4B | $6.0B | $7.6B | $6.6B |
| Deferred Revenue | $2.7B | $3.2B | $0 | $0 | $0 |
| Other Current Liabilities | $2.5B | $1.6B | $6.7B | $5.5B | $5.4B |
| Total Current Liabilities | $17.5B | $18.6B | $23.7B | $23.2B | $20.1B |
| Long-Term Debt | $5.4B | $5.5B | $7.3B | $10.4B | $9.2B |
| Other Non-Current Liab. | $426M | $515M | $444M | $469M | $680M |
| Total Non-Current Liabilities | $11.1B | $10.9B | $11.9B | $16.0B | $15.8B |
| Total Liabilities | $28.6B | $29.6B | $35.7B | $39.2B | $35.9B |
| — Equity — | |||||
| Common Stock | $310M | $310M | $310M | $310M | $335M |
| Retained Earnings | $16.1B | $17.2B | $18.7B | $20.7B | $22.8B |
| Accumulated OCI | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B |
| Total Stockholders Equity | $17.9B | $19.0B | $20.5B | $22.6B | $29.3B |
| Total Liabilities & Equity | $46.3B | $48.6B | $56.2B | $61.8B | $65.2B |
| — Key Metrics — | |||||
| Total Debt | $10.4B | $11.1B | $13.5B | $18.9B | $16.9B |
| Net Debt | $10.3B | $11.1B | $13.2B | $18.1B | $16.6B |
| Total Investments | $3.7B | $3.6B | $3.8B | $4.3B | $3.9B |